Cytonics is on a mission to disrupt the regenerative medicine field with its proprietary and innovative biologic therapies for osteoarthritis. The company is approaching human clinical trials and is raising capital to complete a Phase 1 study.
ClosedOctober 15, 2022
Discover our exclusive features for registered users
Understand when and how people have invested in a campaign with our hourly commitments and investor data.
Benefit from AI-powered company descriptions and other important information.
Access financial statements from various sources in one convenient location.
No subscription required - Wixdom is and will remain free to use! Register now to access our industry-leading crowdfunding data.Sign up for free